Onocor, a company formed through the UPstart program, has entered into an Amended and Restated License Agreement (ARLA) with Penn to expand its existing license to the ONO medical device. The ONO device recently received 510(k) clearance from the FDA and allows for the non-invasive retrieval of misplaced or improperly functioning vascular implants. The ARLA has allowed the Company to enter an exclusive distribution agreement with B. Braun Interventional Systems and adds new Penn IP that builds on the original technology. Read more here.